Načítá se...

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial

INTRODUCTION: Recent findings from onchocerciasis-endemic foci uphold that increasing ivermectin coverage reduces the epilepsy incidence, and anecdotal evidence suggests seizure frequency reduction in persons with onchocerciasis-associated epilepsy, when treated with ivermectin. We conducted a rando...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS Negl Trop Dis
Hlavní autoři: Mandro, Michel, Siewe Fodjo, Joseph Nelson, Mukendi, Deby, Dusabimana, Alfred, Menon, Sonia, Haesendonckx, Steven, Lokonda, Richard, Nakato, Swabra, Nyisi, Francoise, Abhafule, Germain, Wonya’Rossi, Deogratias, Jakwong, Jean Marie, Suykerbuyk, Patrick, Meganck, Jacques, Hotterbeekx, An, Colebunders, Robert
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6977765/
https://ncbi.nlm.nih.gov/pubmed/31923177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0007966
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!